Charney D - Search Results

1

Anxiety and depression: leading edge of therapy.

Mathew S, Charney D. Mathew S, et al. Among authors: charney d. Mt Sinai J Med. 2008 May-Jun;75(3):171-3. doi: 10.1002/msj.20049. Mt Sinai J Med. 2008. PMID: 18704975 No abstract available.

2

Neurobiology of anxiety disorders and implications for treatment.

Garakani A, Mathew SJ, Charney DS. Garakani A, et al. Mt Sinai J Med. 2006 Nov;73(7):941-9. Mt Sinai J Med. 2006. PMID: 17195879 Review.

3

Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder.

Mathew SJ, Price RB, Mao X, Smith EL, Coplan JD, Charney DS, Shungu DC. Mathew SJ, et al. Among authors: charney ds. Biol Psychiatry. 2008 May 1;63(9):891-8. doi: 10.1016/j.biopsych.2007.09.012. Epub 2007 Oct 29. Biol Psychiatry. 2008. PMID: 18028881 Free PMC article. Clinical Trial.

4

Novel drugs and therapeutic targets for severe mood disorders.

Mathew SJ, Manji HK, Charney DS. Mathew SJ, et al. Neuropsychopharmacology. 2008 Aug;33(9):2080-92. doi: 10.1038/sj.npp.1301652. Epub 2008 Jan 2. Neuropsychopharmacology. 2008. PMID: 18172433 Review.

5

Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics.

Mathew SJ, Price RB, Charney DS. Mathew SJ, et al. Am J Med Genet C Semin Med Genet. 2008 May 15;148C(2):89-98. doi: 10.1002/ajmg.c.30172. Am J Med Genet C Semin Med Genet. 2008. PMID: 18412102 Review.

6

Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder.

Price RB, Shungu DC, Mao X, Nestadt P, Kelly C, Collins KA, Murrough JW, Charney DS, Mathew SJ. Price RB, et al. Biol Psychiatry. 2009 May 1;65(9):792-800. doi: 10.1016/j.biopsych.2008.10.025. Epub 2008 Dec 5. Biol Psychiatry. 2009. PMID: 19058788 Free PMC article.

7

Publication bias and the efficacy of antidepressants.

Mathew SJ, Charney DS. Mathew SJ, et al. Am J Psychiatry. 2009 Feb;166(2):140-5. doi: 10.1176/appi.ajp.2008.08071102. Am J Psychiatry. 2009. PMID: 19188290 No abstract available.

8

Neurobiological mechanisms in major depressive disorder.

aan het Rot M, Mathew SJ, Charney DS. aan het Rot M, et al. CMAJ. 2009 Feb 3;180(3):305-13. doi: 10.1503/cmaj.080697. CMAJ. 2009. PMID: 19188629 Free PMC article. Review. No abstract available.

9

Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial.

Mathew SJ, Murrough JW, aan het Rot M, Collins KA, Reich DL, Charney DS. Mathew SJ, et al. Int J Neuropsychopharmacol. 2010 Feb;13(1):71-82. doi: 10.1017/S1461145709000169. Epub 2009 Mar 17. Int J Neuropsychopharmacol. 2010. PMID: 19288975 Free PMC article. Clinical Trial.

10

Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression.

Price RB, Nock MK, Charney DS, Mathew SJ. Price RB, et al. Biol Psychiatry. 2009 Sep 1;66(5):522-6. doi: 10.1016/j.biopsych.2009.04.029. Epub 2009 Jul 9. Biol Psychiatry. 2009. PMID: 19545857 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

722 results

Search Page